Difference between revisions of "Team:SCU-China"

Line 739: Line 739:
 
<div id="Part1" class="row mainlist ">
 
<div id="Part1" class="row mainlist ">
 
  <img id="part1-icon" class="offset-sm-8 col-sm-2" src="https://2019.igem.org/wiki/images/e/e8/T--SCU-China--scu-mainpart-icon2.jpg">
 
  <img id="part1-icon" class="offset-sm-8 col-sm-2" src="https://2019.igem.org/wiki/images/e/e8/T--SCU-China--scu-mainpart-icon2.jpg">
−
   <h1 id="part1-text" class="offset-sm-7 col-sm-5">Earlier than 1756, <i>Cordyceps</i> has been adopted to treat diseases in China.</h1>
+
   <h1 id="part1-text" class="offset-sm-7 col-sm-5">The application of <i>Cordyceps</i> for treating diseases in China can be traced back to the 18th century.</h1>
 
</div>
 
</div>
 
<div id="Part2" class="mainlist row">
 
<div id="Part2" class="mainlist row">
Line 745: Line 745:
 
  <img id="part1-icon" class="offset-sm-2 col-sm-2" src="https://2019.igem.org/wiki/images/8/83/T--SCU-China--scu-mainpart-icon1.jpg">
 
  <img id="part1-icon" class="offset-sm-2 col-sm-2" src="https://2019.igem.org/wiki/images/8/83/T--SCU-China--scu-mainpart-icon1.jpg">
 
<div class="row">
 
<div class="row">
−
   <h1 id="part2-text" class="offset-sm-1 col-sm-5">Nowadays, scientists find cordycepin (COR) in <i>Cordyceps militaris</i> which has a great clinical potential.</h1></div>
+
   <h1 id="part2-text" class="offset-sm-1 col-sm-5">Recently scientists have unveiled the active substance which is of great clinical potential in <i>Cordyceps militaris</i> —— cordycepin(COR) .</h1></div>
 
</div>
 
</div>
 
<div id="Part3" class="mainlist row">
 
<div id="Part3" class="mainlist row">
 
<div id="part3-text" class="row">
 
<div id="part3-text" class="row">
 
   <h1 class="col-3 offset-1">But the price of cordycepin is too high at approximately 1500 dollars per gram.</h1>
 
   <h1 class="col-3 offset-1">But the price of cordycepin is too high at approximately 1500 dollars per gram.</h1>
−
   <h1 class="offset-4 col-3">How can we decrease the price to make a wider usage and more research of COR?</h1>
+
   <h1 class="offset-4 col-3">How can we lower the price of COR to make it more practical in clinical and laboratory settings?</h1>
 
</div>
 
</div>
 
</div>
 
</div>
Line 773: Line 773:
 
  <img class="part6-icon" src="https://2019.igem.org/wiki/images/a/a1/T--SCU-China--scu-home-icon1.png">
 
  <img class="part6-icon" src="https://2019.igem.org/wiki/images/a/a1/T--SCU-China--scu-home-icon1.png">
 
  <h2>Cheap raw materials</h2>
 
  <h2>Cheap raw materials</h2>
−
  <p style="margin-top:10%;">The only cost is the medium which can be very cheap.</p>
+
  <p style="margin-top:10%;">The cost for production is negligible compared to the product.</p>
 
     </div>
 
     </div>
 
     <div class="part6-box center" >
 
     <div class="part6-box center" >
Line 791: Line 791:
  
 
<div id="Part7" class="mainlist row">
 
<div id="Part7" class="mainlist row">
−
   <h1 id="part7-text" class="offset-sm-2 col-sm-9">We performed a market analysis to see whether our project is meaningful. Also, we designed a business plan to do further after iGEM.</h1>
+
   <h1 id="part7-text" class="offset-sm-2 col-sm-9">Market analysis has been conducted to verify the feasibility of our project.
 +
SCU-China have also issued business plans to take CORegulaTIN beyond iGEM.</h1>
 
</div>
 
</div>
  

Revision as of 13:56, 21 October 2019

SCU-China Header

The application of Cordyceps for treating diseases in China can be traced back to the 18th century.

Recently scientists have unveiled the active substance which is of great clinical potential in Cordyceps militaris —— cordycepin(COR) .

But the price of cordycepin is too high at approximately 1500 dollars per gram.

How can we lower the price of COR to make it more practical in clinical and laboratory settings?

Our solution: CORegulaTIN

Advantages

Cheap raw materials

The cost for production is negligible compared to the product.

Automatic fermentation

To avoid pollution
To save labor

Byproduct

We can get pentostatin(PTN) at the same time.

Market analysis has been conducted to verify the feasibility of our project. SCU-China have also issued business plans to take CORegulaTIN beyond iGEM.